Muralitharan Ken Kengatharan

Atheneos Ventures LLC (Atheneos Ventures) is a venture capital firm founded in 2009. The firm is headquartered in Santa Clara, California.

Renexxion LLC is a gastrointestinal biopharmaceutical company. It develops naronapride. The company was founded by Peter G. Milner, Muralitharan Kengatharan , and Pascal J. Druzgala in 2014 and is headquartered in Menlo Park, CA.

Helios Orion Corp. is a corporate strategy advisory firm that partners with innovative healthcare companies in key markets to assist in their growth. The company is based in Santa Clara, CA. The company's experienced team provides plug and play solutions to help these companies succeed.

Auxesia Orion, Inc. offers intelligent therapeutic management for patients with orphan diseases.

Spire Bioventures, Inc. provides consulting services for the healthcare industry.

Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA.

Altheos, Inc. is an early stage biopharmaceutical company based in the San Francisco Bay area focused on development of highly promising near-clinical and clinical stage novel small molecule drugs. Altheos, Inc. was founded by two seasoned pharmaceutical executives, Dr. Henry H. Hsu and Dr. M. (Ken) Kengatharan who have extensive experience in rapid capital efficient drug development as well as financing and growth of early stage biopharmaceutical companies.

CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA.